enGene Holdings Inc. (ENGN)
$1.73-2.81%Close
SELLCRISIS · day 1
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $89M
- Beta
- -0.28
- P/E (TTM)
- -6.43
- Short % float
- 6.48%
- Days to cover
- 1.8
- SI change
- +16.2%
- 1W
- -10.82%
- 1M
- -2.26%
- vs SPY 1W
- -11.99%
- vs SPY 1M
- -5.25%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on ENGN?
- LOPJLB’s latest quantitative signal on enGene Holdings Inc. (ENGN) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is ENGN in?
- enGene Holdings Inc. (ENGN) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does enGene Holdings Inc. (ENGN) do?
- Operating through its subsidiary, enGene, Inc., enGene Holdings Inc. functions as a clinical-stage biotechnology firm. Its core mission involves pioneering genetic pharmaceuticals, achieved by administering therapeutic agents directly to mucosal tissues and other bodily organs. A key asset in its pipeline is EG-70, also known as detalimogene voraplasmid. This innovative non-viral immunotherapy …